(Q34072931)

30 July 2017

title

Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system (English)

1 reference

diffuse large B-cell lymphoma

30 July 2017

1 reference

1 reference

Alexander Baraniskin

1

1 reference

30 July 2017

Martina Deckert

2

1 reference

30 July 2017

Gernot Schulte-Altedorneburg

3

1 reference

30 July 2017

Uwe Schlegel

4

1 reference

30 July 2017

Roland Schroers

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

11 November 2011

1 reference

British Journal of Haematology

30 July 2017

published in

1 reference

30 July 2017

volume

156

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

421-432

1 reference

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

MRI features of primary central nervous system lymphomas at presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Apoptosis and apoptosis-related gene products in primary non-Hodgkin's lymphoma of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Diagnostic delay in primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Assessment of free light chains in the cerebrospinal fluid of patients with lymphomatous meningitis - a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of Epstein-Barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Diagnostic yield of brain biopsy in neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

18F-FDG PET of common enhancing malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

MicroRNAs and haematology: small molecules, big function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Gliomatosis cerebri: disconnection of the cortical grey matter, demonstrated on PET scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Protein biomarker identification in the CSF of patients with CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Epidemiology of primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Evaluation of treatment effects in brain abscess with positron emission tomography: Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08928.X

10.1111/J.1365-2141.2011.08928.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference